Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older — United States, 2018

Morbidity and Mortality Weekly Report

Volumn 67, Issue 5, 2018, Pages 158-160

  Kim, David K ^a   Riley, Laura E ^b   Hunter, Paul ^c  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b HARVARD UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ADULT; ADVISORY COMMITTEE; FEMALE; HUMAN; IMMUNIZATION; MALE; MIDDLE AGED; PRACTICE GUIDELINE; PREGNANCY; PUBLIC HEALTH SERVICE; STANDARDS; UNITED STATES;

ADULT; ADVISORY COMMITTEES; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); FEMALE; HUMANS; IMMUNIZATION; IMMUNIZATION SCHEDULE; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; UNITED STATES; VACCINES;

EID: 85041796394     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6705e3     Document Type: Note

References (11)

1. Smith JC. The structure, role, and procedures of the U.S. Advisory Committee on Immunization Practices (ACIP). Vaccine 2010;28(Suppl 1): A68–75. https://doi.org/10.1016/j.vaccine.2010.02.037
2. Dooling KL, Guo A, Patel M, et al. Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines. MMWR Morb Mortal Wkly Rep 2018;67:103–8.
3. Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 2015;372:2087–96. https://doi.org/10.1056/NEJMoa1501184
4. Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. [Supplementary Appendix]. N Engl J Med 2015;372:2087–96 http://www.nejm.org/doi/suppl/10.1056/NEJMoa1501184/suppl_file/nejmoa1501184_appendix.pdf. https://doi.org/10.1056/NEJMoa1501184
5. Cunningham AL, Lal H, Kovac M, et al.; ZOE-70 Study Group. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med 2016;375:1019–32. https://doi.org/10.1056/NEJMoa1603800
6. Cunningham AL, Lal H, Kovac M, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older [Supplementary Appendix]. N Engl J Med 2016;375:1019–32 http://www.nejm.org/doi/suppl/10.1056/NEJMoa1603800/suppl_file/nejmoa1603800_appendix.pdf. https://doi.org/10.1056/NEJMoa1603800
7. Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP); CDC. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008;57(No. RR-5).
8. Marin M, Marlow M, Moore KL, Patel M. Recommendation of the Advisory Committee on Immunization Practices for use of a third dose of mumps virus–containing vaccine in persons at increased risk for mumps during an outbreak. MMWR Morb Mortal Wkly Rep 2018;67:33–8. https://doi.org/10.15585/mmwr.mm6701a7
9. Advisory Committee on Immunization Practices. Recommended immunization schedule for children and adolescents aged 18 years or younger, United States, 2018. Atlanta, GA: CDC; 2017. https://www.cdc.gov/vaccines/schedules/hcp/child-adolescent.html
10. Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination—updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2016;65:1405–8. https://doi.org/10.15585/mmwr.mm6549a5
11. Kim DK, Riley LE, Hunter P; Advisory Committee on Immunization Practices. Recommended immunization schedule for adults aged 19 years or older, United States, 2018. Ann Intern Med 2018;168:210–20.